Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway

被引:193
作者
Morelli, AE
Larregina, AT
Ganster, RW
Zahorchak, AF
Plowey, JM
Takayama, T
Logar, AJ
Robbins, PD
Falo, LD
Thomson, AW
机构
[1] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Med Ctr, Dept Mol Genet & Biochem, Pittsburgh, PA 15213 USA
[4] Univ Pittsburgh, Med Ctr, Dept Dermatol, Pittsburgh, PA 15213 USA
[5] Univ Pittsburgh, Med Ctr, Inst Canc, Pittsburgh, PA 15213 USA
关键词
D O I
10.1128/JVI.74.20.9617-9628.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recombinant adenovirus (rAd) infection is one of the most effective and frequently employed methods to transduce dendritic cells (DC). Contradictory results have been reported recently concerning the influence of rAd on the differentiation and activation of DC. In this report, we show that, as a result of rAd infection, mouse bone marrow-derived immature DC upregulate expression of major histocompatibility complex class I and II antigens, costimulatory molecules (CD40, CD80, and CD86), and the adhesion molecule CD54 (ICAM-1). rAd-transduced DC exhibited increased allostimulatory capacity and levels of interleukin-6 (IL-6), IL-12p40, IL-15, gamma interferon, and tumor necrosis factor alpha mRNAs, without effects on other immunoregulatory cytokine transcripts such as IL-10 or IL-12p35. These effects were not related to specific transgenic sequences or to rAd genome transcription. The rAd effect correlated with a rapid increase (1 h) in the NF-kappa B-DNA binding activity detected by electrophoretic mobility shift assays. rAd-induced DC maturation was blocked by the proteasome inhibitor N alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK) or by infection with rAd-I kappa B, an rAd-encoding the dominant-negative form of I kappa B. In vivo studies showed that after intravenous administration, rAds were rapidly entrapped in the spleen by marginal zone DC that mobilized to T-cell areas, a phenomenon suggesting that rAd also induced DC differentiation in vivo. These findings may explain the immunogenicity of rAd and the difficulties in inducing long-term antigen-specific T-cell hyporesponsiveness with rAd-transduced DC.
引用
收藏
页码:9617 / 9628
页数:12
相关论文
共 73 条
[21]   Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells [J].
Huang, S ;
Kamata, T ;
Takada, Y ;
Ruggeri, ZM ;
Nemerow, GR .
JOURNAL OF VIROLOGY, 1996, 70 (07) :4502-4508
[22]   THE TISSUE DISTRIBUTION OF THE B7-2 COSTIMULATOR IN MICE - ABUNDANT EXPRESSION ON DENDRITIC CELLS IN-SITU AND DURING MATURATION IN-VITRO [J].
INABA, K ;
WITMERPACK, M ;
INABA, M ;
HATHCOCK, KS ;
SAKUTA, H ;
AZUMA, M ;
YAGITA, H ;
OKUMURA, K ;
LINSLEY, PS ;
IKEHARA, S ;
MURAMATSU, S ;
HODES, RJ ;
STEINMAN, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (05) :1849-1860
[23]   GENERATION OF LARGE NUMBERS OF DENDRITIC CELLS FROM MOUSE BONE-MARROW CULTURES SUPPLEMENTED WITH GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR [J].
INABA, K ;
INABA, M ;
ROMANI, N ;
AYA, H ;
DEGUCHI, M ;
IKEHARA, S ;
MURAMATSU, S ;
STEINMAN, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1693-1702
[24]  
Jobin C, 1998, J IMMUNOL, V160, P410
[25]   Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity [J].
Jonuleit, H ;
Tüting, T ;
Steitz, J ;
Brück, J ;
Giesecke, A ;
Steinbrink, K ;
Knop, J ;
Enk, AH .
GENE THERAPY, 2000, 7 (03) :249-254
[26]   Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression:: Implications for gene therapy [J].
Kafri, T ;
Morgan, D ;
Krahl, T ;
Sarvetnick, N ;
Sherman, L ;
Verma, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (19) :11377-11382
[27]  
Kaplan JM, 1999, J IMMUNOL, V163, P699
[28]   The IκB kinase (IKK) and NF-κB:: key elements of proinflammatory signalling [J].
Karin, M ;
Delhase, M .
SEMINARS IN IMMUNOLOGY, 2000, 12 (01) :85-98
[29]   Gene-modified dendritic cells for use in tumor vaccines [J].
Kirk, CJ ;
Mulé, JJ .
HUMAN GENE THERAPY, 2000, 11 (06) :797-806
[30]   Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-β [J].
Lee, WC ;
Zhong, C ;
Qian, S ;
Wan, Y ;
Gauldie, J ;
Mi, Z ;
Robbins, PD ;
Thomson, AW ;
Lu, L .
TRANSPLANTATION, 1998, 66 (12) :1810-1817